PFIZER – CanAge Collaborate Grant Program 2025

Pfizer and CanAge are collaborating to offer a new grant opportunity seeking grant proposals for programs that seek to explore innovative approaches to persistent challenges impacting older adults living with rare diseases, including but not limited to:

• Accelerating time to diagnosis by increasing understanding of the symptoms (including the distinctions between ageing and illness) through enhanced clinical awareness and integration of genetic testing to identify underlying conditions earlier
• Supporting development of National Action Plans on Rare Disease (RD) to include solutions for the specific challenges faced by older adults and communities ageing with RD
• Gathering existing evidence to support advocacy for closing health care gaps and drive policy change

Eligibility

• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; patient advocacy groups; and other entities with a mission related to healthcare improvement
• Only organizations are eligible to receive grants, not individuals or medical practice groups
• Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project
• The applicant must be the Project Lead or an authorized designee of such individual. The Project Lead must be an employee or contractor of the requesting organization

Budget

Up to USD 100.000 or USD 25.000 for individual projects

Deadline: 24 November 2025